X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/akums-gets-dcgi-nod-for-triple-combination-diabetes-medication/articleshow/102172327.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.indianpharmapost.com/news/glenmark-launches-triple-fdc-of-teneligliptin-with-pioglitazone-and-metformin-for-adults-with-type-2-diabetes-13485
https://health.economictimes.indiatimes.com/news/pharma/glenmark-becomes-the-first-pharmaceutical-company-to-launch-teneligliptin-pioglitazone-fixed-dose-combination-drug-for-type-2-diabetes-in-india/91112044
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-2-2022-1643778781.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-12-2020-1581485052.pdf
https://www.clinicaltrialsarena.com/news/poxel-phaseib-nash-study/
https://www.raps.org/news-and-articles/news-articles/2019/9/ema-begins-testing-heartburn-medicines-for-carcino
https://www.raps.org/news-and-articles/news-articles/2019/4/ema-urges-pioglitazone-manufacturers-to-check-for
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-17-2018-1539751948.pdf
https://www.dddmag.com/news/2018/01/novel-diabetes-drugs-sensitize-cancer-cells-chemotherapy-agents
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-15-2017-1489584258.pdf
http://www.medpagetoday.com/Endocrinology/Diabetes/62022
http://twofourinsight.com/experts-review-banned-drugs-consider-marketing-restrictions-india-mhfw/
http://www.business-standard.com/article/companies/bitter-pill-served-to-1-670-drug-brands-116031900030_1.html
http://cphi-online.com/health-canada-approves-jardiance-tablets-for-news038187.html
http://www.webmd.com/cancer/lymphoma/news/20150902/could-common-diabetes-drugs-help-fight-leukemia?src=RSS_PUBLIC
http://www.bloomberg.com/news/articles/2015-08-13/takeda-s-2-37-billion-drug-accord-endangered-amid-low-sign-ups?
http://www.fiercepharmaasia.com/story/takeda-submits-post-marketing-actos-study-shows-no-link-bladder-cancer/2015-08-03
http://www.news-medical.net/news/20150731/Takeda-completes-post-marketing-commitment-and-data-submission-for-pioglitazone-containing-medicines.aspx?
http://www.fiercepharmaasia.com/story/takeda-ceo-weber-says-turnaround-tempo-quickens-hes-staying-put/2015-04-06
http://www.bloomberg.com/news/articles/2015-04-01/takeda-said-to-offer-2-2-billion-to-settle-actos-drug-cases
http://www.vancpharm.com/wp-content/uploads/2014/12/2014-12-16-News-Release-announcing-additional-molecules.pdf
Market Place
Share 
